Starling Oncology (STLNW) Current Taxes (2020 - 2023)

Starling Oncology (STLNW) has reported Current Taxes for 4 consecutive years, with $255000.0 the latest figure, recorded in Q3 2023.

• For the quarter ending Q3 2023, Current Taxes fell 34.11% year-over-year to $255000.0; the trailing twelve-month figure through Sep 2023 stood at $255000.0 (down 34.11% YoY), and the FY2022 full-year result was $255000.0, up 93.18% from the prior year.
• Current Taxes was little changed at $255000.0 in Q3 2023 per STLNW's latest filing, from $256000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $1.1 million in Q4 2020 and bottomed at $132000.0 in Q4 2021.
• Historically, Current Taxes has averaged $327555.6 across 4 years, with a median of $255000.0 in 2022.
• The sharpest annual moves came in 2021 and 2023: Current Taxes sank 88.46% in 2021, then jumped 93.94% in 2023.
• Over 4 years, Current Taxes stood at $1.1 million in 2020, then tumbled by 88.46% to $132000.0 in 2021, then surged by 93.18% to $255000.0 in 2022, then changed by 0.0% to $255000.0 in 2023.
• According to Business Quant data, Current Taxes over the past three periods registered $255000.0, $256000.0, and $255000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.